Articles

Since 1960, health care’s share of the GDP has risen by an average of 2.2 percentage points per decade, as compared with an average increase of 1.1 percentage points per decade in 15 other high-income countries since the early 1970s.

Among older Americans surveyed in the weeks after FDA approval of aducanumab, few could correctly answer true or false questions about the first new Alzheimer’s drug in decades.

Research shows that medical error is the third leading cause of death worldwide.

Rapid solutions to the opioid crisis remain elusive. Prescriptions for opioids have decreased. Yet, supply limits have not reduced fatalities. Demand-side interventions have not fared any better.

Latino immigrants, especially noncitizens, face a much greater risk of dying than their U.S.-born peers, USC researchers have found.

Insurance companies will inevitably pass the costs of free tests on through higher premiums or reduced benefits.

These findings further reinforce the need for targeted support and resources for families and patients living with Alzheimer’s and other dementias.

More people are living with serious illness as the population ages, and patients with socioeconomic disadvantages bear the greatest burdens of poor care.

California has the opportunity to take the lead on incorporating value-based pricing of health technology in the state healthcare system.

A new USC study shows herd immunity is unlikely to happen.